Form 4: Director Martha Shadan Acquires LMAT Shares

Lemaitre Vascular Director Martha Shadan acquired 5 shares of common stock through the release of dividend equivalent rights.

Summary

• Martha Shadan, a Director at Lemaitre Vascular Inc. (LMAT), acquired 5 shares of the company's common stock.
• The shares were acquired on December 8, 2025, at a price of $0 per share.
• This acquisition resulted from the release of dividend equivalent rights (DERs) associated with previously granted restricted stock units (RSUs) and performance stock units (PSUs).
• Specifically, 2 shares were from DERs connected to an RSU award granted on December 8, 2023, and 3 shares were from DERs connected to a PSU award granted on December 8, 2023.
• Following these transactions, Martha Shadan directly beneficially owns 1,942 shares of Lemaitre Vascular Inc. common stock.

Sentiment

Score: 6

Explanation: The filing reports a routine insider acquisition of a small number of shares through equity award vesting, which is a neutral to slightly positive event as it increases insider ownership, but not significant enough to warrant a high score.

Positives

• Director Martha Shadan increased her direct beneficial ownership of Lemaitre Vascular Inc. common stock by 5 shares.
• The acquisition of shares through vesting mechanisms indicates the fulfillment of long-term incentive awards, aligning management interests with shareholders.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

• Shareholders: Increased insider ownership, albeit minimal, can be seen as a positive signal of alignment with shareholder interests.

Key Dates

Recommendation

This Form 4 filing reports a routine, non-open-market acquisition of a very small number of shares by a director through the vesting of equity awards. Such a transaction is a standard part of executive compensation and does not provide new material information to warrant a change in investment recommendation. It merely reflects a planned increase in insider ownership, which is generally a neutral to slightly positive signal, but not impactful enough to alter a 'hold' stance based solely on this filing.

Keywords

Lemaitre Vascular, LMAT, Martha Shadan, Director, Insider Transaction, Form 4, Common Stock, Dividend Equivalent Rights, Restricted Stock Units, Performance Stock Units, Equity Compensation